Page 1 of Clinical Trials for Celgene Corporation [SPONSOR-COLLABORATORS], 469 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis
Last Updated: April 18, 2012
Condition(s): Rheumatoid Arthritis
2
Not yet recruiting
Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke
Last Updated: March 4, 2011
Condition(s): Stroke, Acute; Middle Cerebral Artery Stroke; Posterior Cerebral Artery Stroke
3
Active, not recruiting
A Multi-Center Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Moderate-to-Severe Crohn's Disease
Last Updated: October 11, 2011
Condition(s): Crohn's Disease
4
Recruiting
Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Stage II or III Pulmonary Sarcoidosis
Last Updated: May 21, 2012
Condition(s): Stage 2 Pulmonary Sarcoidosis; Stage 3 Pulmonary Sarcoidosis
5
Completed
Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma
Last Updated: January 26, 2011
Condition(s): Multiple Myeloma
6
Completed
Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228
Last Updated: March 14, 2011
Condition(s): Renal Cell Carcinoma; Prostate Cancer
7
Terminated
Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis
Last Updated: April 10, 2012
Condition(s): Hemodialysis Graft Dysfunction
8
Terminated
Trial of Romidepsin and Bortezomib for Multiple Myeloma
Last Updated: March 14, 2011
Condition(s): Multiple Myeloma
9
Recruiting
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Last Updated: February 28, 2012
Condition(s): Relapsed or Refractory Chronic Lymphocytic Leukemia
10
Terminated
Study of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer
Last Updated: February 10, 2011
Condition(s): Chemotherapy Induced Anemia
11
Terminated
Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Subjects With Renal Cell Carcinoma
Last Updated: April 9, 2012
Condition(s): Renal Cell Carcinoma
12
Terminated
ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
Last Updated: April 6, 2012
Condition(s): Fallopian Tube Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms
13
Completed
Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy
Last Updated: January 8, 2010
Condition(s): Malignant Melanoma
14
Active, not recruiting
Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer
Last Updated: May 14, 2012
Condition(s): Castrate-Resistant Prostate Cancer
15
Recruiting
To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus
Last Updated: March 6, 2012
Condition(s): Cutaneous Lupus Erythematosus
16
Recruiting
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Last Updated: May 22, 2012
Condition(s): B-Cell Chronic Lymphocytic Leukemia (B-CLL)
17
Active, not recruiting
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
Last Updated: April 17, 2012
Condition(s): Rheumatoid Arthritis
18
Active, not recruiting
Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer
Last Updated: February 8, 2012
Condition(s): Hematologic Malignancy; Malignant Lymphoma
19
Active, not recruiting
Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma
Last Updated: May 7, 2012
Condition(s): Multiple Myeloma
20
Completed
A Phase I/II Study to Determine the MTD and Safety of CC-4047 Administered in Conjunction With Cisplatin and Etoposide
Last Updated: April 9, 2012
Condition(s): Carcinoma, Small Cell

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Celgene+Corporation

Page 1 of Clinical Trials for Celgene Corporation [SPONSOR-COLLABORATORS], 469 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About